May 11, 2015 Sweden
lifesciencesweden.se: Hoppas på stamceller
Diabetesbolaget Diamyd är storägare i biobanken Cellaviva i hopp om stamcellsbaserade behandlingar mot typ 1-diabetes i framtiden.
Läs hela artikeln här
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.